Marcelo Rudzinski
Research Subjects
Research Interests
Marcelo Rudzinski has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Carina Argüelles
Cátedra de Biología Molecular, Universidad Católica de las Misiones , Posadas , Argentina
1 shared publication- Carina Francisca Argüelles
Rare Diseases Community (RDCom), Cambridge, United Kingdom; Facultad de Ciencias de la Salud, Universidad Católica de las Misiones, Misiones, Argentina; Instituto de Biología Subtropical, Nodo Posadas, Universidad Nacional de Misiones (UNaM) - Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Misiones, Argentina
1 shared publication Cristóbal Couto
Departamento de Oftalmología, Hospital de Clínicas José de San Martín , Buenos Aires , Argentina
1 shared publication- Duarte
Facultad de Ciencias de la Salud, Centro de Investigación, Universidad Católica de las Misiones (UCAMI), Posadas, Argentina
1 shared publication - Gastón Moré
Institute of Parasitology, University of Bern, Länggassstrasse 122, 3012, Bern, Switzerland
1 shared publication José R. Oubiña
Instituto de Investigaciones en Microbiología y Parasitología Médica, Universidad de Buenos Aires - Consejo Nacional de Investigaciones Científicas y Técnicas (IMPaM, UBA-CONICET) , Ciudad Autónoma de Buenos Aires , Argentina
1 shared publication
Latest Publications
- Open Access
- 2 December 2020
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 103 (6) , 2239-2243
Interferon-γ and IL-10 Release Assay for Patients with Ocular Toxoplasmosis
Peripheral blood mononuclear cells (PBMCs) from patients with ocular toxoplasmosis were challenged with Toxoplasma gondii lysate antigen (TLA) in a cytokine release assay (CRA), run during the inactive period of the disease. Increased interferon gamma (IFN-γ) levels were detected after PBMC stimulation with either ME49 reference strain (P = 0.0015) or local TgCkAr-11-9 isolate (P = 0.0012), as compared with those recorded under basal conditions. TLA from TgCkAr11-9 isolate induced a higher release of IFN-γ than ME49 strain CRA from all tested patients (P = 0.02). The median value of IFN-γ release on TgCkAr-11-9 stimulation (26.03 pg/mL) allowed the classification of patients into high– or low–/non–IFN-γ releasers. Clinical correlations were established with both groups. The results obtained in this study suggest the need to include local strains when performing CRA with T. gondii TLA.
- 2 December 2020
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 103 (6) , 2239-2243
Open AccessInterferon-γ and IL-10 Release Assay for Patients with Ocular Toxoplasmosis
Peripheral blood mononuclear cells (PBMCs) from patients with ocular toxoplasmosis were challenged with Toxoplasma gondii lysate antigen (TLA) in a cytokine release assay (CRA), run during the inactive period of the disease. Increased interferon gamma (IFN-γ) levels were detected after PBMC stimulation with either ME49 reference strain (P = 0.0015) or local TgCkAr-11-9 isolate (P = 0.0012), as compared with those recorded under basal conditions. TLA from TgCkAr11-9 isolate induced a higher release of IFN-γ than ME49 strain CRA from all tested patients (P = 0.02). The median value of IFN-γ release on TgCkAr-11-9 stimulation (26.03 pg/mL) allowed the classification of patients into high– or low–/non–IFN-γ releasers. Clinical correlations were established with both groups. The results obtained in this study suggest the need to include local strains when performing CRA with T. gondii TLA.
- 6 August 2018
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 27 (6) , 949-957
Immune Mediators against Toxoplasma Gondii during Reactivation of Toxoplasmic Retinochoroiditis
Purpose: The purpose of this article is to analyze possible associations between systemic and ocular cytokine levels and specific clinical ophthalmologic signs from patients with a reactivation of toxoplasmic retinochoroiditis (RTR). Methods: A total of 18 patients with an active RTR episode, 8 patients with inactive scars, and 14 control patients were included in the study. Serum samples and aqueous humor (AH) samples were analyzed for IFN (interferon)-γ, interleukin (IL)-10, and IL-6 levels by ELISA. Inflammation grade, location, and size of the retinochoroidal active lesion, sampling time, and time to resolution were recorded. Results: A significantly negative correlation between AH and serum levels of IFN-γ was detected (p < 0.05). Patients with an AH IFN-γ/IL-10 ratio lower than 1 were associated with the longest time to resolution and/or severe complications. Conclusion: Serum IFN-γ levels may be used as a prognostic marker for both time to resolution and the development of possible severe complications during a given RTR episode.
- 6 August 2018
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 27 (6) , 949-957
Immune Mediators against Toxoplasma Gondii during Reactivation of Toxoplasmic Retinochoroiditis
Purpose: The purpose of this article is to analyze possible associations between systemic and ocular cytokine levels and specific clinical ophthalmologic signs from patients with a reactivation of toxoplasmic retinochoroiditis (RTR). Methods: A total of 18 patients with an active RTR episode, 8 patients with inactive scars, and 14 control patients were included in the study. Serum samples and aqueous humor (AH) samples were analyzed for IFN (interferon)-γ, interleukin (IL)-10, and IL-6 levels by ELISA. Inflammation grade, location, and size of the retinochoroidal active lesion, sampling time, and time to resolution were recorded. Results: A significantly negative correlation between AH and serum levels of IFN-γ was detected (p < 0.05). Patients with an AH IFN-γ/IL-10 ratio lower than 1 were associated with the longest time to resolution and/or severe complications. Conclusion: Serum IFN-γ levels may be used as a prognostic marker for both time to resolution and the development of possible severe complications during a given RTR episode.